Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents - United States, October 31, 2022-May 7, 2023.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
06 Oct 2023
Historique:
medline: 1 11 2023
pubmed: 5 10 2023
entrez: 5 10 2023
Statut: epublish

Résumé

Residents of long-term care (LTC) facilities constitute a population that is vulnerable to SARS-CoV-2 infection; COVID-19 vaccination effectively reduces severe COVID-19 in these settings. To examine demographic differences in primary and up-to-date vaccination status against COVID-19 among LTC facility residents, a descriptive analysis of COVID-19 vaccination data from the National Healthcare Safety Network (NHSN) COVID-19 vaccination data from October 31, 2022, to May 7, 2023, were analyzed. Being up to date was defined as having received a bivalent COVID-19 vaccine dose or having completed a primary vaccination series <2 months earlier. Geographic disparities in vaccination coverage were identified, with substantially lower prevalences of up-to-date status among LTC facility residents in the South (Region 6) (37.7%) and Southeast (Region 4) (36.5%) than among those in the Pacific Northwest (Region 10) (53.3%) and Mountain West (Region 8) (59.6%) U.S. Department of Health and Human Services regions. Up-to-date status was lowest among Black or African American (39.9%) and multiracial (42.2%) LTC facility residents. Strategies to increase up-to-date COVID-19 vaccination among LTC facility residents could include and address these geographic and racial differences.

Identifiants

pubmed: 37796756
doi: 10.15585/mmwr.mm7240a4
pmc: PMC10564329
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1095-1098

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):95-99
pubmed: 36701262
MMWR Morb Mortal Wkly Rep. 2023 Jun 16;72(24):657-662
pubmed: 37319020
MMWR Morb Mortal Wkly Rep. 2021 Jan 15;70(2):52-55
pubmed: 33444301
MMWR Morb Mortal Wkly Rep. 2021 Apr 16;70(15):560-565
pubmed: 33857068
Ann Med. 2021 Dec;53(1):1419-1428
pubmed: 34482788
N Engl J Med. 2021 Jul 29;385(5):474-476
pubmed: 34010526
Vital Health Stat 3. 2022 May;(47):1-93
pubmed: 35604771
Am J Prev Med. 2022 Apr;62(4):473-482
pubmed: 34872772
MMWR Morb Mortal Wkly Rep. 2023 Jun 23;72(25):690-693
pubmed: 37347711

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH